Novartis AG asked a London court on Thursday to ban rival Teva Pharmaceuticals and three other drugmakers from selling any generic versions of a multiple sclerosis drug while the pharmaceutical giant takes the patent battle to trial.
Novartis Asks Court To Ban Generic MS Drug Pending Trial
Latest Intelligence
